(VOVWORLD) - Relevant agencies of the Ministry of Health convened with Nano Covax vaccine research group on Saturday to evaluate results of human trials in phase 1 and 2. The initial results show that the vaccine is safe and produces immunogenicity.
In the third phase of human trial, the research group completed the second injection on 1,000 volunteers and sent samples for independent evaluation at the National Institute of Epidemiology and Hygiene. 12,000 other volunteers have completed the first shots and expected to receive second ones by August 15.
The Ministry of Health says it has shortened administrative procedures during the research and development of the vaccine while ensuring scientific and objective evaluation of the vaccine production.
Nano Covax has been developed by the Nanogen Pharmaceutical Biotechnology JSC based on recombinant DNA/protein technology from May 2020.
It went through the first phase trial from December 18, 2020, and the second phase from February 26, 2021. The third phase started on June 11, 2021.
Results from the first two trial phases showed that all volunteers developed antibodies against SARS-CoV-2.
Vietnam has so far approved six vaccines for emergency use, namely Janssen, Moderna, Sputnik V, Pfizer, Sinopharm and AstraZeneca.
The Government is making efforts to secure at least 150 million vaccine doses to inoculate 70 percent of the population.